The clinical trial success of bepirovirsen, which will be submitted to regulatory agencies for approval, could be a boon for ...

Scientists have found that combining silybin with carvedilol works far better against liver fibrosis than either drug alone.

Immunotherapy-based combinations have rapidly become the dominant first-line treatment for advanced hepatocellular carcinoma ...

Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...

The American Association for the Study of Liver Diseases and Infectious Diseases Society of America have updated guidance on ...

People coinfected with HIV and hepatitis C virus remain at risk for hepatocellular carcinoma within 6 years of starting ...

A new drug combination shows unexpected synergy against liver fibrosis. A new study reveals that using two drugs together produces a much stronger effect than using either one alone, suggesting a ...

Liver cancer remains one of the deadliest cancers worldwide, something that escapes early detection. Understand liver cancer, ...

An oncology pharmacist shares how a treatment takes a different approach to treating chronic graft-versus-host disease (GVHD) ...

Gallbladder cancer is a rare and often aggressive malignancy that develops in the tissues of the gallbladder — a small, ...

But by a wonderful quirk of nature, this fascinating chemical compound was found to inhibit the activation of hepatic ...

The key opportunities in the MASH treatment market include focusing on the drug segment, especially FGF21-based therapies, ...